For a child with epilepsy, every day without a genetic diagnosis is a missed opportunity.
Uncovering an individual’s genetic etiology with comprehensive genetic testing, such as whole exome sequencing (WES) or whole genome sequencing (WGS), offers a more complete understanding of patient health. A genetic diagnosis can provide patients and families greater access to resources and more effective treatment options.
For Clinicians
A genetic diagnosis helps providers tailor treatments and identify, treat and/or prevent co-occurring medical conditions for children with epilepsy. This can include avoiding, stopping, or initiating specific medication or diet recommendations.2
For Families
Patients and families can access prognostic information, evaluate potential recurrence risks, discover resources and communities, and explore clinical trial eligibility for their children with a specific genetic diagnosis.2,4
With 30% fewer uncertain results and higher diagnostic yields, exome testing uncovers the answers hiding behind negative panel results.5
Sponsored testing programs contribute to delayed diagnoses with narrow panels that exclude the genetic analyses needed to deliver answers to patients, their families, and their providers. With higher clinical utility, expert endorsements from AES and NSGC, and rapidly increasing accessibility, exome provides definitive answers to end the diagnostic odyssey.
Our dedicated team of genetic counselors provides peer-to-peer support as well as genetic counseling for GeneDx patients at no additional cost, or through our independent partners, pusuant to patient insurance requirements. Our interpretation services focus on providing clinically actionable results, so you can quickly apply findings to your patients’ care plans.
Your patients are looking for answers. Find them with GeneDx.
References